Combination Plerixafor (AMD3100)and Bortezomib in Relapsed or Relapsed/Refractory Multiple Myeloma

This study is currently recruiting participants.

Verified December 2012 by Dana-Farber Cancer Institute

Study NCT00903968 Information provided by Dana-Farber Cancer Institute

First Received on May 18, 2009. Last Updated on December 5, 2012 History of Changes

Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:

Conditions listed in this trial

Multiple Myeloma

Additional conditions recognized in this trial

More general conditions related to this trial

Interventions listed in this trial

Plerixafor (AMD3100)
bortezomib

Additional drug interventions recognized in this trial

JM 3100

More general drug interventions related to this trial

Sponsors listed in this trial